Cyproheptadine Hydrochloride Tablet
Product Images NDC 70752-232

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyproheptadine Hydrochloride (NDC 70752-232). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quagen Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Chemsture)

Chemical structure of cyproheptadine hydrochloride, showing its molecular framework and elemental composition with a molecular weight of 350.89.*

FDA Label Image

Containerlabels30s (Containerlabels30s)

Label for Cyprolaria tablets containing 2 mg cyproheptadine HCl, USP, manufactured by Pangea Pharmaceuticals. The label shows the product name, dosage strength, tablet count of 30, NDC 81279-129-30, storage instructions, and a barcode. It also includes a warning to keep medication out of children's reach and notes the product is made in the USA.*

FDA Label Image

Containerlabels60s (Containerlabels60s)

Label for Cyprolatra 2 mg Tablets, USP (cyproheptadine HCl) manufactured by Pangea Pharmaceuticals. The label indicates 60 tablets per container, with storage instructions at 20° to 25°C and a child-resistant closure requirement. It includes warnings to keep medications out of children's reach and lists the NDC 81279-129-60.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.